| Stage | ITT | % of rev | SPXC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $715M | 100.00% | ITT ×2.06 |
| Gross profit | $510M | 34.63% | $280M | 39.12% | SPXC +4.5pp |
| Operating income | $180M | 12.24% | $115M | 16.14% | SPXC +3.9pp |
| Pre-tax income | $135M | 9.18% | $106M | 14.88% | SPXC +5.7pp |
| Net income | $87M | 5.87% | $82M | 11.46% | SPXC +5.6pp |
| Stage | ITT | SPXC | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $715M100.00% | ITT ×2.06 |
| Gross profit | 34.63%$510M | 39.12%$280M | SPXC +4.5pp |
| Operating income | 12.24%$180M | 16.14%$115M | SPXC +3.9pp |
| Pre-tax income | 9.18%$135M | 14.88%$106M | SPXC +5.7pp |
| Net income |
| 5.87%$87M |
| 11.46%$82M |
| SPXC +5.6pp |
No shared counterparties.